Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Trends in Launch Prices and Price Increases for Self-Administered Anticancer Drugs in Medicare.
Journal: JAMA
Published: May 15, 2025
Author Correction: The high costs of anticancer therapies in the USA: challenges, opportunities and progress.
Journal: Nature reviews. Clinical oncology
Published: October 31, 2024
Impact of race, ethnicity, and social determinants on outcomes following immune checkpoint therapy.
Journal: Journal for immunotherapy of cancer
Published: October 03, 2024
The high costs of anticancer therapies in the USA: challenges, opportunities and progress.
Journal: Nature reviews. Clinical oncology
Published: September 19, 2024
SOHO State of the Art Updates and Next Questions | Immunotherapeutic Options for Patients With Mantle Cell Lymphoma Who Progress on BTK Inhibitors.
Journal: Clinical lymphoma, myeloma & leukemia
Published: August 08, 2023
The Inflation Reduction Act: How Will Medicare Negotiating Drug Prices Impact Patients with Heart Disease?
Journal: Current cardiology reports
Published: April 01, 2023
Estimation of Out-of-Pocket Costs for Guideline-Directed Medical Therapy for Heart Failure Under Medicare Part D and the Inflation Reduction Act.
Journal: JAMA cardiology
Published: January 11, 2023
Maintenance therapy for AML after allogeneic HCT.
Journal: Frontiers in oncology
Published: March 14, 2022
Financial toxicity in cancer care: origins, impact, and solutions.
Journal: Translational behavioral medicine
Published: December 01, 2021
Public-sector Contributions to Novel Biologic Drugs.
Journal: JAMA internal medicine
Published: July 19, 2021
Characteristics of Public vs. Private Federally Qualified Health Centers.
Journal: Journal of general internal medicine
Published: December 06, 2020
Last Updated: 09/26/2026